Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.68
BATS BZX Real-Time Price
As of 9:46am ET
 +0.67 / +1.59%
Today’s Change
36.71
Today|||52-Week Range
44.85
+7.29%
Year-to-Date
Pfizer Champix's Label to Include More Data, Warning Lifted
10:02am / Zacks.com - Paid Partner Content
AstraZeneca's Severe Asthma Drug Positive in Phase III
May 18 / Zacks.com - Paid Partner Content
3 Stocks With a Bigger Dividend Than Coca-Cola
9:38am / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals' Zika Vaccine Takes a Big Step Forward
May 17 / MotleyFool.com - Paid Partner Content
The Best Buys in Biopharma Today
9:12am / MotleyFool.com - Paid Partner Content
Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact
May 12 / Zacks.com - Paid Partner Content
Glaxo/Innoviva Unveil SUMMIT Study Data on Breo Ellipta
May 19 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Reports Narrower-than-Expected Q1 Loss
May 10 / Zacks.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Inc Is Burning Partners' Cash (Thank Goodness There's Lots of I...
May 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close42.01
Today’s open42.58
Day’s range42.58 - 42.74
Volume56,037
Average volume (3 months)3,678,431
Market cap$102.3B
Dividend yield5.47%
Data as of 9:46am ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+13.83%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-3.66%
P/E ratio169.9
Price/Sales2.70
Price/Book13.49

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.52+1.32%
NVONovo Nordisk+1.01+1.88%
ABBVAbbVie+1.05+1.77%
AGNAllergan+3.14+1.39%
Data as of 9:46am ET, 05/24/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs